296 related articles for article (PubMed ID: 33682961)
1. Serum exosomal microRNAs as predictive markers for EGFR mutations in non-small-cell lung cancer.
Xia J; Luo M; Dai L; Wang L; Wang L; Zhu J
J Clin Lab Anal; 2021 May; 35(5):e23743. PubMed ID: 33682961
[TBL] [Abstract][Full Text] [Related]
2. Correlation of plasma exosomal microRNAs with the efficacy of immunotherapy in
Peng XX; Yu R; Wu X; Wu SY; Pi C; Chen ZH; Zhang XC; Gao CY; Shao YW; Liu L; Wu YL; Zhou Q
J Immunother Cancer; 2020 Jan; 8(1):. PubMed ID: 31959728
[TBL] [Abstract][Full Text] [Related]
3. The expression of circulating miR-504 in plasma is associated with EGFR mutation status in non-small-cell lung carcinoma patients.
Szpechcinski A; Florczuk M; Duk K; Zdral A; Rudzinski S; Bryl M; Czyzewicz G; Rudzinski P; Kupis W; Wojda E; Giedronowicz D; Langfort R; Barinow-Wojewodzki A; Orlowski T; Chorostowska-Wynimko J
Cell Mol Life Sci; 2019 Sep; 76(18):3641-3656. PubMed ID: 30953094
[TBL] [Abstract][Full Text] [Related]
4. Exosomal microRNAs as potential biomarkers for osimertinib resistance of non-small cell lung cancer patients.
Janpipatkul K; Trachu N; Watcharenwong P; Panvongsa W; Worakitchanon W; Metheetrairut C; Oranratnachai S; Reungwetwattana T; Chairoungdua A
Cancer Biomark; 2021; 31(3):281-294. PubMed ID: 33896827
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miRNA profiling before and after surgery revealed potential diagnostic and prognostic markers for lung adenocarcinoma.
Xue X; Wang C; Xue Z; Wen J; Han J; Ma X; Zang X; Deng H; Guo R; Asuquo IP; Qin C; Wang H; Gao Q; Liu S; Wang J
Acta Biochim Biophys Sin (Shanghai); 2020 Mar; 52(3):281-293. PubMed ID: 32073597
[TBL] [Abstract][Full Text] [Related]
6. Identification of plasma microRNA profiles for primary resistance to EGFR-TKIs in advanced non-small cell lung cancer (NSCLC) patients with EGFR activating mutation.
Wang S; Su X; Bai H; Zhao J; Duan J; An T; Zhuo M; Wang Z; Wu M; Li Z; Zhu J; Wang J
J Hematol Oncol; 2015 Nov; 8():127. PubMed ID: 26563758
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Evaluation of Circulating miRNA Profile in
Leonetti A; Capula M; Minari R; Mazzaschi G; Gregori A; El Hassouni B; Papini F; Bordi P; Verzè M; Avan A; Tiseo M; Giovannetti E
Cells; 2021 Jun; 10(6):. PubMed ID: 34208765
[TBL] [Abstract][Full Text] [Related]
8. Exosomal miR-338-3p suppresses non-small-cell lung cancer cells metastasis by inhibiting CHL1 through the MAPK signaling pathway.
Tian W; Yang X; Yang H; Lv M; Sun X; Zhou B
Cell Death Dis; 2021 Oct; 12(11):1030. PubMed ID: 34718336
[TBL] [Abstract][Full Text] [Related]
9. Plasma miR-1247-5p, miR-301b-3p and miR-105-5p as potential biomarkers for early diagnosis of non-small cell lung cancer.
Dong X; Chang M; Song X; Ding S; Xie L; Song X
Thorac Cancer; 2021 Feb; 12(4):539-548. PubMed ID: 33372399
[TBL] [Abstract][Full Text] [Related]
10. Serum miR-1228-3p and miR-181a-5p as Noninvasive Biomarkers for Non-Small Cell Lung Cancer Diagnosis and Prognosis.
Xue WX; Zhang MY; Rui Li ; Liu X; Yin YH; Qu YQ
Biomed Res Int; 2020; 2020():9601876. PubMed ID: 32724822
[TBL] [Abstract][Full Text] [Related]
11. Circulating serum exosomal miR-20b-5p and miR-3187-5p as efficient diagnostic biomarkers for early-stage non-small cell lung cancer.
Zhang ZJ; Song XG; Xie L; Wang KY; Tang YY; Yu M; Feng XD; Song XR
Exp Biol Med (Maywood); 2020 Oct; 245(16):1428-1436. PubMed ID: 32741216
[TBL] [Abstract][Full Text] [Related]
12. A novel circulating miRNA-based signature for the early diagnosis and prognosis prediction of non-small-cell lung cancer.
Zhou C; Chen Z; Zhao L; Zhao W; Zhu Y; Liu J; Zhao X
J Clin Lab Anal; 2020 Nov; 34(11):e23505. PubMed ID: 33463758
[TBL] [Abstract][Full Text] [Related]
13. Serum MiRNA as Predictive and Prognosis Biomarker in Advanced Stage Non-small Cell Lung Cancer in Indonesia.
Hanafi AR; Jayusman AM; Alfasunu S; Sadewa AH; Pramono D; Heriyanto DS; Haryana SM
Zhongguo Fei Ai Za Zhi; 2020 May; 23(5):321-332. PubMed ID: 32283582
[TBL] [Abstract][Full Text] [Related]
14. microRNA-let-7e in serum-derived exosomes inhibits the metastasis of non-small-cell lung cancer in a SUV39H2/LSD1/CDH1-dependent manner.
Xu S; Zheng L; Kang L; Xu H; Gao L
Cancer Gene Ther; 2021 Apr; 28(3-4):250-264. PubMed ID: 33299140
[TBL] [Abstract][Full Text] [Related]
15. Identification of differentially expressed circulating serum microRNA for the diagnosis and prognosis of Indian non-small cell lung cancer patients.
Kumar S; Sharawat SK; Ali A; Gaur V; Malik PS; Kumar S; Mohan A; Guleria R
Curr Probl Cancer; 2020 Aug; 44(4):100540. PubMed ID: 32007320
[TBL] [Abstract][Full Text] [Related]
16. Serum exosomal miR-378 upregulation is associated with poor prognosis in non-small-cell lung cancer patients.
Zhang Y; Xu H
J Clin Lab Anal; 2020 Jun; 34(6):e23237. PubMed ID: 32061007
[TBL] [Abstract][Full Text] [Related]
17. Correlation of exosomal microRNA clusters with bone metastasis in non-small cell lung cancer.
Yang XR; Pi C; Yu R; Fan XJ; Peng XX; Zhang XC; Chen ZH; Wu X; Shao Y; Wu YL; Zhou Q
Clin Exp Metastasis; 2021 Feb; 38(1):109-117. PubMed ID: 33231826
[TBL] [Abstract][Full Text] [Related]
18. Tumor-associated exosomal miRNA biomarkers to differentiate metastatic vs. nonmetastatic non-small cell lung cancer.
Wang N; Guo W; Song X; Liu L; Niu L; Song X; Xie L
Clin Chem Lab Med; 2020 Aug; 58(9):1535-1545. PubMed ID: 32271158
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived exosomal miR-619-5p promotes tumor angiogenesis and metastasis through the inhibition of RCAN1.4.
Kim DH; Park S; Kim H; Choi YJ; Kim SY; Sung KJ; Sung YH; Choi CM; Yun M; Yi YS; Lee CW; Kim SY; Lee JC; Rho JK
Cancer Lett; 2020 Apr; 475():2-13. PubMed ID: 32004570
[TBL] [Abstract][Full Text] [Related]
20. Serum miR-339-3p as a potential diagnostic marker for non-small cell lung cancer.
Trakunram K; Chaniad P; Geater SL; Keeratichananont W; Chittithavorn V; Uttayamakul S; Buya S; Raungrut P; Thongsuksai P
Cancer Biol Med; 2020 Aug; 17(3):652-663. PubMed ID: 32944397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
